clinical trial glp 1 New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks Care Access | Weight Loss

Optional add-ons (labs, extra consultations) are not included

Some feel let down when theyre charged cancellation fees even though they never received medication: Others describe paying for memberships, visits, and prescriptions, only to end up disappointed with the results or the lack of clear communication: Overall, reviews show a mixed picture

69 AstraZeneca has also entered the field, and AZD6234 is in the early stages of developing an amylin analog

The SURMOUNT-1 trial reported -22.5% weight reduction at the 15 mg weekly dose across 72 weeks (PMID 35658024)

[DOI] [PMC free article] [PubMed] [Google Scholar] 211.Baggio, L

doi: 10.1212/WNL.0000000000208642